These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 11748980)
1. Psychological adjustment to familial-genetic risk assessment for ovarian cancer: predictors of nonadherence to surveillance recommendations. Ritvo P; Irvine J; Robinson G; Brown L; Murphy KJ; Matthew A; Rosen B Gynecol Oncol; 2002 Jan; 84(1):72-80. PubMed ID: 11748980 [TBL] [Abstract][Full Text] [Related]
2. A longitudinal study of psychological adjustment to familial genetic risk assessment for ovarian cancer. Ritvo P; Robinson G; Irvine J; Brown L; Murphy KJ; Stewart DS; Styra R; Wang C; Mullen M; Cole D; Rosen B Gynecol Oncol; 1999 Sep; 74(3):331-7. PubMed ID: 10479489 [TBL] [Abstract][Full Text] [Related]
3. Cancer risk perceptions and distress among women attending a familial ovarian cancer clinic. Cull A; Fry A; Rush R; Steel CM Br J Cancer; 2001 Mar; 84(5):594-9. PubMed ID: 11237377 [TBL] [Abstract][Full Text] [Related]
4. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. Watson M; Lloyd S; Davidson J; Meyer L; Eeles R; Ebbs S; Murday V Br J Cancer; 1999 Feb; 79(5-6):868-74. PubMed ID: 10070883 [TBL] [Abstract][Full Text] [Related]
5. Coping with ovarian cancer risk: the moderating effects of perceived control on coping and adjustment. Fang CY; Daly MB; Miller SM; Zerr T; Malick J; Engstrom P Br J Health Psychol; 2006 Nov; 11(Pt 4):561-80. PubMed ID: 17032484 [TBL] [Abstract][Full Text] [Related]
6. Coping with genetic testing for breast cancer susceptibility. Dougall AL; Smith AW; Somers TJ; Posluszny DM; Rubinstein WS; Baum A Psychosom Med; 2009 Jan; 71(1):98-105. PubMed ID: 19124622 [TBL] [Abstract][Full Text] [Related]
7. Spiritual faith and genetic testing decisions among high-risk breast cancer probands. Schwartz MD; Hughes C; Roth J; Main D; Peshkin BN; Isaacs C; Kavanagh C; Lerman C Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):381-5. PubMed ID: 10794482 [TBL] [Abstract][Full Text] [Related]
8. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer. Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771 [TBL] [Abstract][Full Text] [Related]
9. Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer. Antill Y; Reynolds J; Young MA; Kirk J; Tucker K; Bogtstra T; Wong S; Dudding T; Di Iulio J; Phillips KA Eur J Cancer; 2006 Mar; 42(5):621-8. PubMed ID: 16434187 [TBL] [Abstract][Full Text] [Related]
10. Psychological distress and quality of life associated with genetic testing for breast cancer risk. Smith AW; Dougall AL; Posluszny DM; Somers TJ; Rubinstein WS; Baum A Psychooncology; 2008 Aug; 17(8):767-73. PubMed ID: 17992698 [TBL] [Abstract][Full Text] [Related]
11. Does dispositional optimism predict psychological responses to counseling for familial breast cancer? Norman P; Brain K J Psychosom Res; 2007 Sep; 63(3):247-54. PubMed ID: 17719361 [TBL] [Abstract][Full Text] [Related]
12. Women at risk of ovarian cancer. Wardle J J Natl Cancer Inst Monogr; 1995; (17):81-5. PubMed ID: 8573460 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of psychological distress among women with ovarian cancer. Norton TR; Manne SL; Rubin S; Carlson J; Hernandez E; Edelson MI; Rosenblum N; Warshal D; Bergman C J Clin Oncol; 2004 Mar; 22(5):919-26. PubMed ID: 14990648 [TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589 [TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer. Tiller K; Meiser B; Gaff C; Kirk J; Dudding T; Phillips KA; Friedlander M; Tucker K Med Decis Making; 2006; 26(4):360-72. PubMed ID: 16855125 [TBL] [Abstract][Full Text] [Related]
16. Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers. Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Lubsen-Brandsma L; Massuger LF; Mourits MJ; Gaarenstroom KN; van Dorst EB; van der Putten H; Boonstra H; Aaronson NK J Clin Oncol; 2007 Jan; 25(3):301-7. PubMed ID: 17235045 [TBL] [Abstract][Full Text] [Related]
17. Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. Manne SL; Chung DC; Weinberg DS; Vig HS; Catts Z; Cabral MK; Shannon K; Meropol NJ Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2110-7. PubMed ID: 17932359 [TBL] [Abstract][Full Text] [Related]
18. No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result. Dorval M; Gauthier G; Maunsell E; Dugas MJ; Rouleau I; Chiquette J; Plante M; Laframboise R; Gaudet M; Bridge PJ; Simard J Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2862-7. PubMed ID: 16365001 [TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of a brief self-help coping intervention designed to reduce distress when awaiting genetic risk information. Bennett P; Phelps C; Brain K; Hood K; Gray J J Psychosom Res; 2007 Jul; 63(1):59-64. PubMed ID: 17586338 [TBL] [Abstract][Full Text] [Related]
20. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information. DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]